+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CRISPR"

US Cell & Gene Therapy Market - Focused Insights 2023-2028 - Product Thumbnail Image

US Cell & Gene Therapy Market - Focused Insights 2023-2028

  • Report
  • May 2023
  • United States
From
U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027

  • Report
  • November 2022
  • 197 Pages
  • United States
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
CRISPR Technology: Global Markets - Product Thumbnail Image

CRISPR Technology: Global Markets

  • Report
  • January 2023
  • 131 Pages
  • Global
From
The Chinese Market for DNA Sequencing - Product Thumbnail Image

The Chinese Market for DNA Sequencing

  • Report
  • September 2025
  • 82 Pages
  • China
From
DNA Sequencing: Research, Applied and Clinical Markets - Product Thumbnail Image

DNA Sequencing: Research, Applied and Clinical Markets

  • Report
  • December 2024
  • 168 Pages
  • Global
From
Cell and Gene Therapy Tools and Reagents Market - Product Thumbnail Image

Cell and Gene Therapy Tools and Reagents Market

  • Report
  • November 2024
  • 136 Pages
  • Global
From
CRISPR Technology Market - Product Thumbnail Image

CRISPR Technology Market

  • Report
  • October 2024
  • 122 Pages
  • Global
From
Global Cell and Gene Therapy Market - Product Thumbnail Image

Global Cell and Gene Therapy Market

  • Report
  • March 2024
  • 145 Pages
  • Global
From
Epigenetic Therapeutics: Global Markets - Product Thumbnail Image

Epigenetic Therapeutics: Global Markets

  • Report
  • June 2023
  • 155 Pages
  • Global
From
Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy - Product Thumbnail Image

Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • Report
  • December 2021
  • 353 Pages
  • Global
From
Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow, Indication, Culture Type, and Region - Analysis and Forecast, 2023-2033 - Product Thumbnail Image

Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow, Indication, Culture Type, and Region - Analysis and Forecast, 2023-2033

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032 - Product Thumbnail Image

Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032

  • Report
  • February 2024
  • 77 Pages
  • Asia Pacific
From
Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032 - Product Thumbnail Image

Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032

  • Report
  • January 2024
  • 93 Pages
  • Europe
From
Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032 - Product Thumbnail Image

Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032

  • Report
  • May 2023
  • 240 Pages
  • Global
From
Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031 - Product Thumbnail Image

Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031

  • Report
  • March 2022
  • 273 Pages
  • Global
From
CRISPR Gene Editing Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Country-Wise Analysis - Analysis and Forecast, 2020-2031 - Product Thumbnail Image

CRISPR Gene Editing Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Country-Wise Analysis - Analysis and Forecast, 2020-2031

  • Report
  • December 2021
  • 296 Pages
  • Global
From
U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report by Service (Site Identification, Patient Recruitment), Phase (Phase I, Phase II), Therapeutic Areas, Therapy Type, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report by Service (Site Identification, Patient Recruitment), Phase (Phase I, Phase II), Therapeutic Areas, Therapy Type, and Segment Forecasts, 2024-2030

  • Report
  • November 2023
  • 183 Pages
  • United States
From
Advances in Gene Editing Technologies in Healthcare - Product Thumbnail Image

Advances in Gene Editing Technologies in Healthcare

  • Report
  • January 2023
  • 103 Pages
  • Global
From
Growth Opportunities in Gene Editing Technologies, Advanced Biomanufacturing, Drug Discovery and Precision Medicine - Product Thumbnail Image

Growth Opportunities in Gene Editing Technologies, Advanced Biomanufacturing, Drug Discovery and Precision Medicine

  • Report
  • November 2022
  • 54 Pages
  • Global
Loading Indicator

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population. The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more